TY - JOUR
T1 - Pulmonary Procedures During the COVID-19 Pandemic
T2 - A Work Group Report of the AAAAI Asthma Diagnosis and Treatment (ADT) Interest Section
AU - Virant, Frank S.
AU - Randolph, Chris
AU - Nanda, Anil
AU - Baptist, Alan P.
AU - Akuthota, Praveen
AU - Adams, Karla
AU - Quinn, James M.
AU - Pongdee, Thanai
AU - Nyenhuis, Sharmilee M.
N1 - Publisher Copyright:
© 2022 American Academy of Allergy, Asthma & Immunology
PY - 2022/6
Y1 - 2022/6
N2 - The COVID-19 pandemic has placed increased demands on the ability to safely perform pulmonary procedures in keeping with Centers for Disease Control and Prevention (CDC), American Thoracic Society (ATS), and the Occupational Safety and Health Administration (OSHA) recommendations. Accordingly, the American Academy of Allergy, Asthma & Immunology (AAAAI) Asthma Diagnosis and Treatment convened this work group to offer guidance. The work group is composed of specialist practitioners from academic and both large and small practices. Individuals with special expertise were assigned sections on spirometry, fractional exhaled nitric oxide, nebulized treatments, and methacholine challenge. The work group met periodically to achieve consensus. This resulting document has recommendations for the allergy/asthma/immunology health care setting based on available evidence including reference documents from the CDC, ATS, and OSHA.
AB - The COVID-19 pandemic has placed increased demands on the ability to safely perform pulmonary procedures in keeping with Centers for Disease Control and Prevention (CDC), American Thoracic Society (ATS), and the Occupational Safety and Health Administration (OSHA) recommendations. Accordingly, the American Academy of Allergy, Asthma & Immunology (AAAAI) Asthma Diagnosis and Treatment convened this work group to offer guidance. The work group is composed of specialist practitioners from academic and both large and small practices. Individuals with special expertise were assigned sections on spirometry, fractional exhaled nitric oxide, nebulized treatments, and methacholine challenge. The work group met periodically to achieve consensus. This resulting document has recommendations for the allergy/asthma/immunology health care setting based on available evidence including reference documents from the CDC, ATS, and OSHA.
KW - COVID-19
KW - FeNO (exhaled nitric oxide)
KW - Methacholine challenge
KW - Nebulized medication
KW - Pulmonary function testing
KW - Pulmonary procedures
KW - SARS-CoV-2
KW - Spirometry
UR - http://www.scopus.com/inward/record.url?scp=85128213111&partnerID=8YFLogxK
U2 - 10.1016/j.jaip.2022.02.044
DO - 10.1016/j.jaip.2022.02.044
M3 - Article
C2 - 35431153
AN - SCOPUS:85128213111
SN - 2213-2198
VL - 10
SP - 1474
EP - 1484
JO - Journal of Allergy and Clinical Immunology: In Practice
JF - Journal of Allergy and Clinical Immunology: In Practice
IS - 6
ER -